Collaborative Efforts in Early Detection and Intervention for Alzheimer’s Disease

Bridging Community: Collaborative Efforts in Early Detection and Intervention for Alzheimer’s Disease is an innovative educational program tailored for family medicine physicians, as well as primary care practitioners—including OB/GYNs, NPs, PAs—alongside general neurologists, psychiatrists, and other members of the interprofessional healthcare team. This program empowers clinicians who play a pivotal role in identifying and managing patients at risk of early Alzheimer’s disease (AD) and cognitive impairment.

 

This initiative features a blended learning experience combining an enduring on-demand component with interactive in-person sessions hosted by local AAFP chapters. Participants will gain actionable insights from expert faculty, who will explore:

Live AAFP chapter meetings offer a unique opportunity to connect with faculty and peers, fostering collaboration and shared learning. Through case-based discussions and sharing multidisciplinary perspectives, attendees will deepen their understanding of clinical challenges and refine their approach to AD patient care.

 

Accreditation, Support and Credit
This activity is provided by MLI

 

In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

The AAFP has reviewed Bridging Community: Collaborative Efforts in Early Detection and Intervention for Alzheimer's Disease and deemed it acceptable for up to 1.0 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 01/22/2025 to 01/14/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

PA

Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) toward AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until January 14, 2026. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioner
The American Academy of Nurse Practitioners (AANP) Certification Board recognizes and accepts continuing education (CE) credits/contact hours from activities approved by AMA,ACCME, ANCC, AANP, and AAFP.

Support Statement
This activity is supported by an educational grant from Lilly.

Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

 

Ariel Cole, MD, CMD, FAAFP
Director, AdventHealth Geriatric Medicine Fellowship

Geriatrics Clerkship Director, Orlando Campus

Florida State University College of Medicine

Winter Park, FL, USA

 

Ariel Cole, MD, CMD, FAAFP, has no relevant financial relationships with ineligible companies to disclose for this educational activity. 

 

Alireza Atri, MD, PhD
Chief Medical Officer, Banner Research
Director, Banner Sun Health Research Institute

Sun City, AZ, USA

 

Alireza Atri, MD, PhD, has a financial interest/relationship or affiliation in the form of:

Consultant/Advisor: Eisai, Life Molecular Imaging, Novo Nordisk

Research Support/Grant: ACTC, ADCS, Alzheon, Athira, AZ Alzheimer’s Research Consortium and AZ DHS, ATRI, GAP, Biogen, Biohaven, Eisai, Foundation for NIH (FNIH), Gates Ventures, Indiana University, Johns Hopkins, Lilly, NIA/NIH, USC, Vivoryon, Washington University St. Louis

Other: Royalties or licenses: Oxford University Press / Support for attending meetings and/or travel: Alzheimer’s Association (US), Alzheimer’s Disease International (ADI), American Academy of Neurology (AAN), Michael J Fox Foundation (MJFF)

Consultant/Advisor: AriBio (ad hoc), Axsome, Lundbeck, Merck, ONO (ad hoc), Prothena, Vaxxinity

 

Anton P. Porsteinsson, MD
William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine

Director, Alzheimer's Disease Care, Research and Education Program (AD-CARE) 

University of Rochester School of Medicine

Rochester, NY, USA

 

Anton P. Porsteinsson, MD, has a financial interest/relationship or affiliation in the form of:

Consultant/Advisor: Acadia Pharmaceuticals, Athira, Axsome, Biogen, Bristol Myers Squibb, Cognitive Research Corp, Eisai, IQVIA, Lundbeck, Novartis, ONO Pharmaceuticals, Otsuka, WCG, WebMD, and Xenon

Research Support (grants to institution): Alector, Athira, Biogen, Cassava, Eisai, Eli Lilly, Genentech/Roche, Vaccinex, NIA, NIMH, and DOD

 

Elizabeth Poynor, MD, PhD
Chair, Women's Health and Gynecology Atria Institute

Clinical Professor Obstetrics and Gynecology, NYU Langone

New York, NY, USA

 

Elizabeth Poynor, MD, PhD, has no relevant financial relationships with ineligible companies to disclose for this educational activity. 

 

All of the relevant financial relationships of individuals for this activity have been mitigated.